Article Details
Retrieved on: 2021-04-28 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Roche Venture Fund, New Enterprise Associates (NEA), Sant Ventures, and UCB. Lumos Pharmas lead therapeutic candidate is LUM-201, an oral ...
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here